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SUMMARY
In electrophysiological terms, experimental
models of durable information storage in the
brain include long-term potentiation (LTP),
long-term depression, and kindling. Protein
synthesis correlates with these enduring
processes. We propose a fourth example of
long-lasting information storage in the brain,
which we call the GABA-withdrawal syndrome
(GWS). In rats, withdrawal of a chronic
intracortical infusion of GABA, a ubiquitous
inhibitory neurotransmitter, induced epilepto-
genesis at the infusion site. This overt GWS lasted
for days. Anisomycin, a protein synthesis
inhibitor, prevented the appearance of GWS
in vivo. Hippocampal and neocortical slices
showed a similar post-GABA hyperexcitability
in vitro and an enhanced susceptibility to LTP
induction. One to four months after the epileptic
behavior disappeared, systemic administration
of a subconvulsant dose of pentylenetetrazol
produced the reappearance of paroxysmal
activity. The long-lasting effects of tonic
GABAA receptor stimulation may be involved
in long-term information storage processes at
the cortical level, whereas the cessation of
GABAA receptor stimulation may be involved
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in chronic pathological conditions, such as
epilepsy. Furthermore, we propose that GWS
may represent a common key factor in the
addiction to GABAergic agents (for example,
barbiturates, benzodiazepines, and ethanol).
GWS represents a novel form of neurono-glial
plasticity. The mechanisms of this phenomenon
remain to be understood.
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INTRODUCTION
Over the past few years, we have been
involved in studies addressing GABA-mediated
inhibition in several different models of epilepsy.
In photo-sensitive baboons and in kindled rats,
we have demonstrated that intracortically applied
GABA has powerful anticonvulsant effects
(Fukuda, 1987; Brailowsky, 1989). In all cases,
we observed that cessation of GABA infusion
was associated with the appearance of
epileptogenic activity at the site of the GABA
infusion (Brailowsky, 1987). Phenomenologically,
we named this event the "GABA-withdrawal
syndrome (GWS)".
Although originally described in the baboon,
GWS was also induced in the rat somatomotor cortex
(Bmilowsky, 1988), hippocampus, and amygdala (Le
Gal la Salle, 1988). We also showed, using a 100
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gg/laL/h dose, an inverse relation between GABA
infusion time (from 6 h to 2 wk) and the latency and
duration ofepileptogenic activity (Brailowsky, 1988).
With this procedure, a 3-h infusion ofGABA was not
effective in inducing GWS. We later found that
hippocampal slices, perfused with GABA for 120
min, show an enhanced response to electrical
stimulation and decreased paired-pulse during the
washing period, GABA-mediated inhibition (Garcia-
Ugalde, 1992).
Searching for neurotransmitter receptor speci-
ficit and for the minimum time of continuous
GABA infusion that is required for inducing GWS,
we produced a long-lasting GWS after a relatively
short intracortical infusion of either GABA or
GABAA agonist. The absence of an effect using
antagonists of the excitatory neurotransmitter
glutamate further suggests that the GWS
phenomenon is mainly dependent, at least in the
first stages, on changes in inhibitory mechanisms.
TABLE 1
of epileptogenic EEG activity consecutive to intracortical microinfusion of various Occurrence agents.
Drug
GABA
Aniso ->
GABA+Aniso.
Aniso + GABA
Isoguvacine
THIP
GABA -> APH
-GABA-> CNQX
Glycine
Dose
50 mM
100 mM
500 mM
75 mM->+
0.5 M
75 mM+
0.5M
61 mM
10 mM
1 mM
100 tM
10 mM
mM
100 tM
0.5 M ->
444 mM
0.5 M ->
100 tM
0.5 M
Infusion time
(min)
120
120
120
60
30
15
60-> 120
120
120’
15"
2*
120"
120"
120
2*
2*
2
120, 180
120, 180
7 days
120
% GWS
76.9(13)
100 (11)
O0 (9)
84.6(13)
58.3 (12)
0(8)
0 (4)
0 (4)
100 (7)
100 (2)
100 (7)
O0 (8)
0(5)
0 (2)
0 (4)
0 (4)
0 (2)
Latency
(min)
35.2+/-3.4
39.9+6.5
95.4+/-10.2
115.0+/-7.1
99.74-11.8
127.8+/-39.9
158.5+
232.5+13.3
Duration
(days)
2.2+0.4
3.3+0.5
7.0+0.4
3.27+0.9
7.0+2.0
11.42:0.6
6.5+
5.0:0.6
(8)
0(4)
0 (4)
98.6+/-7.7
100+22.7
98.8+ 11.3
1.5+/-0.5
6.0+/-1.8
2.8+0.9
percent of subjects
2All infusions, except the acute (0.4 laL in 2 min) infusion, were performed at a rate of 3 laL/h. Latency (in min) and
duration (in days) ofGWS are indicated (mean+s.e.m.). Aniso anisomycin; The antibiotic was given either before
and/or with GABA. * doses that induced EEG slowing during drug infusion. Other abbreviations are given in the
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EXPERIMENTAL METHODS
Experiments were performed in male Wistar
rats (200 to 250g), prepared for chronic
recording and intracortical infusion (Brailowsky,
1988). One week after surgery, saline or
pharmacological agents (listed in Table 1) were
unilaterally applied into the cortex for various
periods of time. In separate groups of animals,
immediately after GABA or saline disconnection,
the respective NMDA and AMPA/quisqualate
receptor antagonists, 444 mM APH (aminophos-
phonoheptanoate) and 1001aM CNQX (6-cyano-
7-nitrouinoxaline-2,3-dione), were administered
locally at tL/h for 180 min. All drug and saline
solutions contained 0.2 mg/mL of direct blue to
mark the infusion site and the diffusion area. The
rats were sacrificed either 10 d after the electrical
signs of GWS had disappeared or 30 to 120 d
after overt GWS had disappeared, but with the
administration of PTZ or its vehicle (saline)
before the sacrifice (see below). The brains were
processed for Nissl staining and for glial
fibrillary acidic protein (GFAP) immunohisto-
chemistry (Hsu, 1981).
RESULTS
In all animals in which GABA was successfully
infused, except those of the 15-min infusion group,
GWS was observed (Table 1). The GABAA agonists
L
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Fig. 1: An example of a GWS-like syndrome induced by acute, intracortically administered isoguvacine, a specific
GABAA agonist, into the left somatomotor cortex. The latency for the appearance of the first epileptic spike
was 213 min after injection. Insert: Micrograph of a coronal section of the rat brain processed for glial-
fibrillar acidic protein (GFAP) immunoreactivity. Note the astrocytic reaction in the GABA-infused side,
both at the cortical site and in ipsilateral thalamic structures (arrows).T. MONTIEL ET AL.
used, isoguvacine and THIP, induced GWS with
electrographic features similar to those induced by
GABA (Table 1). It is noteworthy that acute micro-
injections of isoguvacine (2 min) were effective in
inducing paroxysmal activity for 5 d or more (see
Table and Fig. 1).
Histological analysis showed an area of gliosis at
the cortical infusion site and in the thalamic
projection site, in particular on the upper portion of
the ventrolateral (VL) and posterior groups, and in
the reticular nucleus (Fig. 1). GWS induction was
not prevented by either APH or CNQX, which
when given alone, had no effect.
Intracortical administration of glycine
produced neither a behavioral nor an EEG
abnormality in the 200-min follow-up period
after drug infusion. Sixty to 120 days after the
electrical signs of GWS disappeared, rats were
injected systemically with a subconvulsant dose
(20 to 25 mg/kg i.p.) of PTZ, a widely used
epileptogenic agent (Dedeyn, 1992), or with the
PTZ vehicle (saline). In 12 of 14 rats, PTZ
induced the reappearance of localized, high-
voltage paroxysmal activity at the GABA-infused
site, similar to the previous GWS and lasting
from 60 to 90 min (Fig. 2).
In search of a possible relation between the in
vitro analog of GWS and in vitro long-term
potentiation (LTP) (Bliss, 1993), we treated cortical
slices with GABA, applying the same methods as
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Fig. 2: An example of the electrographic changes typical of a GWS induced after 120 min of continuous
intracortical GABA infusion. GABA was applied into the left somatomotor cortex (MCx). The effects of
i.p. injection of pentylenetetrazol (20 mg/kg) 4 months after the disappearance of electrographic signs of
GWS epileptogenesis are also shown. Note the reactivation at the cortical focus, with characteristics similar
to those observed originally.LONG-LASTING EFFECTS OF GABA IN RAT CEREBRAL CORTEX
those used with hippocampal slices. We found that
(a) cortical slices also show hyperexcitability after
GABA incubation (Fig. 3), and (b) electrical
stimulation that failed to produce LTP (40 Hz, 200
ms 10, at 0.2 Hz) in control slices (n-3) elicited
a further enhancement of the already facilitated
response in GWS slices (n=4) and most notably,
the appearance of additional components.
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Fig. 3: In vitro induction of cortical GWS and the effects of electrical stimulation. Longitudinal brain slices (400
lam), obtained from anesthetized young adult (150 g) Wistar rats, were incubated for 60 min in Ringer-Krebs
solution and then for 120 min in 5 mM GABA, followed by a wash. The graph plots the slope of the rising
phase of the various components (indicated by symbols) of the population evoked response (e.p.s.p.),
recorded from the superficial layers (I-II) of the cortex in response to test stimuli applied to the deep (V-VI)
cortical layers. Each point represents the average of 10 responses. The first response is shown in empty
circles, the second component, indicated by arrows, is illustrated with filled squares, and in triangles, a late
component that appeared after GWS induction and electrical stimulation (40 Hz for 200 ms 10, at 0.2 Hz).
(A) control response; (B) response after GWS induction and electrical stimulation. Note that GABA
incubation produced an inhibition of the e.p.s.p, response, followed by a facilitation of about 350%.
Electrical stimulation, applied at the arrow, produced a further enhancement of the response of about 100%
and the appearance of an additional component (filled triangle) in the response. Calibration: 5 mV, 10 ms.T. MONTIEL ET AL.
DISCUSSION
Both the qualitative and quantitative features
of the GWS found in this study are comparable to
those previously observed (Brailowsky, 1988) in
rats, in which a 6-h GABA infusion time was
laL/h. It is thus possible that by increasing the
infusion rate, we obtained a larger GABA
diffusion and, therefore, a larger population of
affected cells; alternatively, a saturation ofGABA
transport or remover processes, or both may have
occurred.
Among the GABAA agonists, the quantitative
differences in GWS may be related to their phar-
macokinetic profiles: isoguvacine remains longer
in the extracellular space because it is not taken
up, whereas THIP is known for its short duration
of action (Krogsgaard-Larsen, 1994). This
distinction may explain why an acute micro-
injection of isoguvacine was as effective as a 30
min GABA infusion.
The specificity of the effects of GABA is
supported by
a) the lack of abnormalities observed after
the cessation of glycine infusion;
b) the effects of specific GABAA agonists
(this study), and
c) the potentiation of GWS produced by
the neurosteroid allopregnanolone, an
allosteric modulator of the GABAA
receptor (Calixto, 1995).
The participation of GABAu receptors in the
induction of GWS can be excluded because
baclofen does not produce withdrawal signs (on
the contrary, the drug itself induces paroxysmal
activity). In addition, the specific GABA
antagonists, phaclofen and CGP 35348, do not
modify GWS features (Brailowsky, 1995). In
addition, GWS was not prevented by the
glutamate receptor antagonists APH or CNQX.
In the current study, we also confirmed the
histological changes previously reported by
Brailowsky (1988), both at the infusion site and
in ipsilateral thalamic areas, adding immuno-
histochemical evidence (GFAP staining) of
astrocytic participation in this reaction. The
thalamic changes are similar to those reported
with cortical epileptogenic foci that were induced
with convulsant agents, such as bicuculline or
penicillin, and shown to be excitotoxic in nature
because they can be prevented by NMDA
antagonists (Clifford, 1989). We propose that
this event, gliosis, is but one manifestation of
many important changes that are occurring in
glial function. An explanation of these events
will be critical to understanding the mechanisms
involved in GWS.
Chronic GABA exposure may induce the
creation of some form of "epileptic" GABAA
receptor or an enhanced vulnerability to seizures,
or both. For example, in Angelman syndrome, a
clinical condition in which epileptic seizures are
frequent, a deletion of genes encoding the
GABAA receptor subunits, alpha-5, beta-3, and
gamma-3, in chromosome 15ql 1-13, has been
reported (Mclean, 1995).
The GABAA receptor is a member of the
superfamily of ionotropic receptors comprising
several subunits, whose combination determines
the particular pharmacology reported for diverse
brain regions (Olsen, 1990; Macdonald, 1994).
This property of allosteric modulation is relevant
to widely used and clinically important drugs,
such as the benzodiazepines, barbiturates, neuro-
steroids, and ethanol. After chronic administra-
tion, all these drugs, except the neurosteroids,
can induce physical dependence and withdrawal
signs. A common neurochemical mechanism
involving GABA function has been suggested for
such abstinence symptoms (Cowen, 1982). The
premenstrual syndrome has been proposed to be
a possible withdrawal syndrome to progesterone,
a positive modulator of the GABAg receptor
(Gallo, 1993). A progesterone metabolite, al|o-
pregnano|one, significantly potentiates GWS
(Calixto, 1995). Despite the clinical differences
in these withdrawal syndromes, an understanding
of the pathophysiology ofGWS may enable us to
decipher the mechanisms responsible for sedative,
anxyiolitic, and hypnotic drug addiction, aLONG-LASTING EFFECTS OF GABA IN RAT CEREBRAL CORTEX
significant epidemiological problem in many
countries. In fact, GWS may represent a common
key factor in all such addictions.
A fascinating result of this study was the long-
lasting (months) consequence of a relatively short
exposure to GABA or to GABA agonists (but not
to glycine), protracted effects that could be
unmasked by the systemic administration of PTZ
(but not saline), even 4 months after the apparent
disappearance of epileptogenic activity. If we
consider such enduring epileptogenic activity as a
synaptic expression that is analogous to memory
(an "epileptogenic" experience), then a role for
GABA in memory processes (conceived as
cellular information storage) can be postulated.
A further suggestion for a relation between
GWS and information storage derives from our
results with anisomycin, an inhibitor of protein
synthesis. A wide variety of experimental
models, from snails to humans, have demon-
strated that when administered from h before
and up to 7 h after a training or sensitization
procedure, antibiotics like anisomycin induce
amnesia to the task (Barzilai, 1989; Oleary,
1995). Anisomycin blocks GWS induction and,
interestingly, also interferes with drug dependence
(Williams, 1994).
The GWS is a remarkable example of
synaptic plasticity; its basic mechanism, neuronal
and glial, may be analyzed from the rich
perspectives offered by studies in epilepsy, drug
dependence, and information storage.
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